← Eichor
Condition: Nontuberculous Mycobacteria Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Nontuberculous Mycobacteria

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)
Phase 2 · 2 location(s) · Barwon Health · NCT06481163TGF β 1 Expression Related Gene Polymorphism
Phase N/A · 1 location(s) · Aswan University · NCT06683690Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Phase 2 · 8 location(s) · Kevin Winthrop · NCT05730283Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05597280Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Phase 2/Phase 3 · 50 location(s) · The University of Queensland · NCT04310930Controls for Respiratory Diseases
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT03120481Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease
Phase N/A · 1 location(s) · Shanghai Pulmonary Hospital, Shanghai, China · NCT05824988Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients
NA · 1 location(s) · South Valley University · NCT06819449IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Phase 1 · 10 location(s) · Chris Goss · NCT04294043Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnos
NA · 1 location(s) · University of Brasilia · NCT07515989Trauma-Informed Motivational Interviewing in Rural Dwelling Samples
NA · 1 location(s) · Alexandria University · NCT06909734Leprosy Active Searching Trial in Brazil
NA · 1 location(s) · Hospital Alemão Oswaldo Cruz · NCT06761469Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Phase 2 · 1 location(s) · Kevin Winthrop · NCT07301320Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)
Phase 2 · 1 location(s) · University of Virginia · NCT07094711Evaluation Of The Lung Microbiome In NTM Bronchiectasis
Phase N/A · 1 location(s) · NYU Langone Health · NCT02779478Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
Phase 2 · 6 location(s) · Oxford University Clinical Research Unit Indonesia · NCT05243654Novel Interventions and Diagnostic Tests for Leprosy
NA · 1 location(s) · Annemieke Geluk · NCT06222372Study of Mycobacterial Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00018044Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease
NA · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT07647575SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Phase 2 · 1 location(s) · Nancy Klimas · NCT07021794Hypertonic Saline for MAC
Phase 4 · 3 location(s) · Oregon Health and Science University · NCT04921943Treatment Monitoring for NTM Infections With a Symptom Diary
Phase N/A · 3 location(s) · Research Center Borstel · NCT07131774Mycobacteria Registry Study: Prospective Observational Study in Austria
Phase N/A · 3 location(s) · Ludwig Boltzmann Institute for Lung Health · NCT06522347Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
Phase 4 · 1 location(s) · Radboud University Medical Center · NCT05192057Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Phase N/A · 1 location(s) · University of North Carolina, Chapel Hill · NCT06155747Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
Phase N/A · 1 location(s) · University College, London · NCT07192705M. Avium WGS During Mav-PD Treatment
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT06266442
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.